Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Combined treatment of hidradenitis suppurativa with Intense Pulsed Light (IPL) and Radiofrequency (RF).

Wilden S, Friis M, Tuettenberg A, Staubach-Renz P, Wegner J, Grabbe S, von Stebut E.

J Dermatolog Treat. 2019 Oct 14:1-24. doi: 10.1080/09546634.2019.1677842. [Epub ahead of print]

PMID:
31609667
2.

GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme.

Zimmer N, Kim E, Sprang B, Leukel P, Khafaji F, Ringel F, Sommer C, Tuettenberg J, Tuettenberg A.

Int J Mol Sci. 2019 Jul 26;20(15). pii: E3676. doi: 10.3390/ijms20153676.

3.

BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells.

Hajek E, Krebs F, Bent R, Haas K, Bast A, Steinmetz I, Tuettenberg A, Grabbe S, Bros M.

Oncotarget. 2018 Jun 19;9(47):28294-28308. doi: 10.18632/oncotarget.25511. eCollection 2018 Jun 19.

4.

Sentinel lymph node biopsy in malignant melanoma of the head and neck.

Rahimi-Nedjat RK, Al-Nawas B, Tuettenberg A, Sagheb K, Grabbe S, Walter C.

J Craniomaxillofac Surg. 2018 Jun;46(6):1027-1031. doi: 10.1016/j.jcms.2018.04.011. Epub 2018 Apr 12.

PMID:
29735384
5.

Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.

Foerster F, Boegel S, Heck R, Pickert G, Rüssel N, Rosigkeit S, Bros M, Strobl S, Kaps L, Aslam M, Diken M, Castle J, Sahin U, Tuettenberg A, Bockamp E, Schuppan D.

Oncoimmunology. 2017 Dec 26;7(4):e1409929. doi: 10.1080/2162402X.2017.1409929. eCollection 2018.

6.

Novel Concept of CD4-Mediated Activation of Regulatory T Cells for the Treatment of Graft-Versus-Host Disease.

Schlöder J, Berges C, Tuettenberg A, Jonuleit H.

Front Immunol. 2017 Nov 8;8:1495. doi: 10.3389/fimmu.2017.01495. eCollection 2017. Review.

7.

Targeting myeloid cells in the tumor sustaining microenvironment.

Schupp J, Krebs FK, Zimmer N, Trzeciak E, Schuppan D, Tuettenberg A.

Cell Immunol. 2019 Sep;343:103713. doi: 10.1016/j.cellimm.2017.10.013. Epub 2017 Nov 2. Review.

PMID:
29129292
8.

Dendritic Mesoporous Silica Nanoparticles for pH-Stimuli-Responsive Drug Delivery of TNF-Alpha.

Kienzle A, Kurch S, Schlöder J, Berges C, Ose R, Schupp J, Tuettenberg A, Weiss H, Schultze J, Winzen S, Schinnerer M, Koynov K, Mezger M, Haass NK, Tremel W, Jonuleit H.

Adv Healthc Mater. 2017 Jul;6(13). doi: 10.1002/adhm.201700012. Epub 2017 May 29.

PMID:
28557249
9.

Asymptomatische, erworbene symmetrische Läsionen am Augeninnenwinkel.

Wilden S, Lang B, Weidenthaler-Barth B, Grabbe S, Tuettenberg A.

J Dtsch Dermatol Ges. 2017 Mar;15(3):842-844. doi: 10.1111/ddg.13068_g. No abstract available.

PMID:
28252866
10.

Acquired symmetric asymptomatic lesions at the inner corners of the eyes.

Wilden S, Lang B, Weidenthaler-Barth B, Grabbe S, Tuettenberg A.

J Dtsch Dermatol Ges. 2017 Mar;15(3):342-344. doi: 10.1111/ddg.13068. No abstract available.

PMID:
28252865
11.

SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.

Leber N, Kaps L, Aslam M, Schupp J, Brose A, Schäffel D, Fischer K, Diken M, Strand D, Koynov K, Tuettenberg A, Nuhn L, Zentel R, Schuppan D.

J Control Release. 2017 Feb 28;248:10-23. doi: 10.1016/j.jconrel.2016.12.006. Epub 2016 Dec 9.

PMID:
27940184
12.

Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.

Tuettenberg A, Steinbrink K, Schuppan D.

Nanomedicine (Lond). 2016 Oct;11(20):2735-2751. Epub 2016 Sep 23. Review.

PMID:
27658725
13.

Dextran-based therapeutic nanoparticles for hepatic drug delivery.

Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, Radi L, Diken M, Strand D, Tuettenberg A, Wich PR, Schuppan D.

Nanomedicine (Lond). 2016 Oct;11(20):2663-2677. Epub 2016 Sep 15.

PMID:
27628057
14.

A key role of GARP in the immune suppressive tumor microenvironment.

Hahn SA, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, Bros M, Weilbaecher M, Schuppan D, Grabbe S, Tueting T, Lennerz V, Sommer C, Jonuleit H, Tuettenberg A.

Oncotarget. 2016 Jul 12;7(28):42996-43009. doi: 10.18632/oncotarget.9598.

15.

How Soluble GARP Enhances TGFβ Activation.

Fridrich S, Hahn SA, Linzmaier M, Felten M, Zwarg J, Lennerz V, Tuettenberg A, Stöcker W.

PLoS One. 2016 Apr 7;11(4):e0153290. doi: 10.1371/journal.pone.0153290. eCollection 2016.

16.

GARP inhibits allergic airway inflammation in a humanized mouse model.

Meyer-Martin H, Hahn SA, Beckert H, Belz C, Heinz A, Jonuleit H, Becker C, Taube C, Korn S, Buhl R, Reuter S, Tuettenberg A.

Allergy. 2016 Sep;71(9):1274-83. doi: 10.1111/all.12883. Epub 2016 Apr 1.

PMID:
26990894
17.

Kinome Profiling of Regulatory T Cells: A Closer Look into a Complex Intracellular Network.

Tuettenberg A, Hahn SA, Mazur J, Gerhold-Ay A, Scholma J, Marg I, Ulges A, Satoh K, Bopp T, Joore J, Jonuleit H.

PLoS One. 2016 Feb 16;11(2):e0149193. doi: 10.1371/journal.pone.0149193. eCollection 2016.

18.

[Localized, irregular pigmentation of the maxillary gingiva].

Rahimi-Nedjat RK, Sagheb K, Tuettenberg A, Renné C, Walter C.

Hautarzt. 2016 Apr;67(4):326-30. doi: 10.1007/s00105-016-3763-9. German. No abstract available.

PMID:
26861127
19.

Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.

Ulges A, Klein M, Reuter S, Gerlitzki B, Hoffmann M, Grebe N, Staudt V, Stergiou N, Bohn T, Brühl TJ, Muth S, Yurugi H, Rajalingam K, Bellinghausen I, Tuettenberg A, Hahn S, Reißig S, Haben I, Zipp F, Waisman A, Probst HC, Beilhack A, Buchou T, Filhol-Cochet O, Boldyreff B, Breloer M, Jonuleit H, Schild H, Schmitt E, Bopp T.

Nat Immunol. 2015 Mar;16(3):267-75. doi: 10.1038/ni.3083. Epub 2015 Jan 19.

PMID:
25599562
20.

Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin.

Schweda K, Hainz M, Loquai C, Grabbe S, Saloga J, Tuettenberg A.

Int J Dermatol. 2015 Apr;54(4):462-4. doi: 10.1111/ijd.12022. Epub 2014 Apr 2. No abstract available.

PMID:
24697249
21.

Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.

Rudolph BM, Loquai C, Gerwe A, Bacher N, Steinbrink K, Grabbe S, Tuettenberg A.

Exp Dermatol. 2014 Mar;23(3):202-4. doi: 10.1111/exd.12336.

PMID:
24495013
22.

Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells.

Hahn SA, Stahl HF, Becker C, Correll A, Schneider FJ, Tuettenberg A, Jonuleit H.

Blood. 2013 Aug 15;122(7):1182-91. doi: 10.1182/blood-2012-12-474478. Epub 2013 Jul 1.

PMID:
23818544
23.

Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.

Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H.

Front Immunol. 2013 Apr 3;4:82. doi: 10.3389/fimmu.2013.00082. eCollection 2013.

24.

Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.

Vaeth M, Schliesser U, Müller G, Reissig S, Satoh K, Tuettenberg A, Jonuleit H, Waisman A, Müller MR, Serfling E, Sawitzki BS, Berberich-Siebelt F.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16258-63. doi: 10.1073/pnas.1203870109. Epub 2012 Sep 18.

25.

Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical application.

Tuettenberg A, Becker C, Correll A, Steinbrink K, Jonuleit H.

Clin Lab. 2011;57(1-2):1-12. Review.

PMID:
21391459
26.

Research in practice: Regulatory T cells - targets for therapeutic approaches?

Jonuleit H, Tuettenberg A, Steinbrink K; Working Group Dermatologic Research (Abeitsgemeinschaft Dermatologische Forschung, ADF).

J Dtsch Dermatol Ges. 2011 Jan;9(1):8-11. doi: 10.1111/j.1610-0387.2010.07503.x. Epub 2010 Sep 7. Review. English, German.

PMID:
21166772
27.
28.

CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.

Tuettenberg A, Fondel S, Steinbrink K, Enk AH, Jonuleit H.

Exp Dermatol. 2010 Jan;19(1):44-53. doi: 10.1111/j.1600-0625.2009.00975.x. Epub 2009 Nov 2.

29.

The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells.

Tuettenberg A, Huter E, Hubo M, Horn J, Knop J, Grimbacher B, Kroczek RA, Stoll S, Jonuleit H.

J Immunol. 2009 Mar 15;182(6):3349-56. doi: 10.4049/jimmunol.0802733.

30.

Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.

Balkow S, Loser K, Krummen M, Higuchi T, Rothoeft T, Apelt J, Tuettenberg A, Weishaupt C, Beissert S, Grabbe S.

Exp Dermatol. 2009 Jan;18(1):78-87. doi: 10.1111/j.1600-0625.2008.00800.x. Epub 2008 Oct 22.

PMID:
19054060
31.

Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.

Tuettenberg A, Schmitt E, Knop J, Jonuleit H.

J Dtsch Dermatol Ges. 2007 Mar;5(3):190-6. Review. English, German.

PMID:
17338793
32.

Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.

Tuettenberg A, Koelsch S, Knop J, Jonuleit H.

Exp Dermatol. 2007 Mar;16(3):171-8.

PMID:
17286808
33.

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.

Tuettenberg A, Becker C, Huter E, Knop J, Enk AH, Jonuleit H.

Int J Cancer. 2006 May 15;118(10):2617-27.

34.

Dendritic cells: sentinels of immunity and tolerance.

Kubach J, Becker C, Schmitt E, Steinbrink K, Huter E, Tuettenberg A, Jonuleit H.

Int J Hematol. 2005 Apr;81(3):197-203. Review.

PMID:
15814330
35.

Diversity and recognition efficiency of T cell responses to cancer.

Stuge TB, Holmes SP, Saharan S, Tuettenberg A, Roederer M, Weber JS, Lee PP.

PLoS Med. 2004 Nov;1(2):e28. Epub 2004 Nov 30.

36.

Early adenoviral gene expression mediates immunosuppression by transduced dendritic cell (DC): implications for immunotherapy using genetically modified DC.

Tuettenberg A, Jonuleit H, Tüting T, Brück J, Biermann V, Kochanek S, Knop J, Enk AH.

J Immunol. 2004 Feb 1;172(3):1524-30.

37.

[Septic thrombosis of the cavernous sinus due to folliculitis].

Tuettenberg A, Tuettenberg J, Knop J, Enk A.

Hautarzt. 2003 Apr;54(4):351-3. Epub 2003 Jan 15. German.

PMID:
12669208
39.

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.

Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH.

J Exp Med. 2001 Jun 4;193(11):1285-94.

Supplemental Content

Loading ...
Support Center